Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Sight Sciences, a US-based eyecare technology company specializing in minimally invasive glaucoma and dry eye treatment devices, will report its first quarter 2026 financial results on May 6, 2026. The company will hold a conference call to discuss these results. This update reiterates the company’s ongoing commitment to advancing interventional ey…
Beeline Holdings, a digital mortgage fintech company listed on NASDAQ under the ticker BLNE, announced it will hold a stakeholder update call on May 14, 2026, to review its Q1 2026 financial results and discuss ongoing initiatives. The call will be hosted by the CEO and CFO and is available via webcast and toll-free dial-in.
Oculis Holding AG has published its invitation to the 2026 Annual General Meeting scheduled for May 13, 2026, in Zug, Switzerland, including details for in-person attendance and webcast access. Additionally, the company will host a shareholder information session on May 11, focusing on meeting proposals and company updates. Oculis continues to adva…
AvePoint, a leader in AI data protection and governance, announced it will report its Q1 2026 financial results on May 7, 2026, followed by a conference call to discuss financial performance and business trends. The company provides unified data security and resilience solutions across multiple cloud platforms, serving over 28,000 customers globall…
Foghorn Therapeutics presented new preclinical data demonstrating the efficacy and safety of its innovative drug candidates targeting chromatin regulatory proteins involved in cancer. The lead compound, selective SMARCA2 inhibitor FHD-909, in combination with an anti-PD-1 antibody, showed complete and durable tumor regression and immune memory in m…
Monarch Casino & Resort, Inc. reported record financial results for Q1 2026, with net revenue increasing 8.9% to $136.6 million and net income rising 38.9% to $27.6 million compared to the prior year. Adjusted EBITDA grew 19% and margins improved significantly. The company increased market share at both its Atlantis and Monarch Black Hawk propertie…
Beta Bionics announced a 57% year-over-year increase in net sales for Q1 2026, driven by growth in both Durable Medical Equipment and Pharmacy Benefit Plan channels. The company improved its gross margin significantly and reduced its net loss compared to Q1 2025. Beta Bionics also raised its full-year 2026 revenue and gross margin guidance, reflect…
Olema Oncology announced it will present initial Phase 1 clinical data for its investigational drug OP-3136, a novel selective KAT6A/B inhibitor, at the 2026 ASCO Annual Meeting. The company will also provide updates on its ongoing Phase 3 OPERA-02 trial involving palazestrant plus ribociclib for advanced breast cancer. OP-3136 shows potent anti-pr…
Wave Life Sciences, a biotechnology company developing RNA-based medicines, has filed for shareholder and Singapore High Court approvals to redomicile its parent company from Singapore to the United States. The move aims to position the company advantageously for future growth and regulatory alignment, subject to customary approvals and closing con…
TrustCo Bank Corp NY reported a net income of $16.3 million for the first quarter of 2026, a 14.1% increase from the prior year. The bank's net interest income grew 10.7% to $44.7 million due to successful loan portfolio repricing and disciplined deposit pricing strategies, which led to a 20 basis point expansion in net interest margin to 2.84%. Lo…
Cytokinetics, a biopharmaceutical company specializing in cardiac muscle biology, announced its plan to release first quarter 2026 financial results on May 5, 2026, followed by a management conference call to discuss its financial performance and business updates. The company is advancing its pipeline of cardiac therapies, including the approved dr…
Belite Bio has initiated the rolling submission of a New Drug Application (NDA) to the FDA for tinlarebant, an oral therapy aimed at treating Stargardt disease type 1 (STGD1). The drug has received Breakthrough Therapy Designation and is backed by positive Phase 3 clinical data. The company plans to complete submission by Q2 2026 and is preparing f…
A court in San Salvador opened a mass trial on April 21 for 486 individuals accused of leading the Mara Salvatrucha gang, in a case alleging more than 47,000 crimes committed between 2012 and 2022. Prosecutors have presented autopsies, ballistic reports and witness testimony and have requested maximum sentences that could reach 245 years per defend…
Hasbro shares declined after a report that the company informed a unit of Indian manufacturer Aequs it intended to stop placing purchase orders. UBS analyst Arpine Kocharyan flagged the report and said it could be an early sign of impact from a cybersecurity incident Hasbro disclosed on April 1, though Hasbro has told reporters the supplier move is…
Christopher Bohrson, Senior Vice President and Chief Customer Officer at Cohu Inc. (NASDAQ: COHU), sold 1,000 shares of company stock worth $38,000 on April 15, 2026, under a pre-arranged 10b5-1 plan adopted November 21, 2025. The company has simultaneously reported $30 million in follow-on orders for its Eclipse testing platform and received sever…
Zachary W. Bawel, a director of German American Bancorp, Inc. (NASDAQ:GABC), purchased $999 of common stock through the company’s Dividend Reinvestment and Stock Purchase Plan on April 15, 2026. The acquisition, executed at $43.58 per share, added 22.9463 shares to his position. The company recently reported stronger-than-expected fourth-quarter 20…
Vicor Corp's Chairman and CEO Patrizio Vinciarelli sold 40,000 shares of common stock on April 16, 2026, in transactions totaling about $7.91 million executed under a pre-arranged Rule 10b5-1 trading plan. The Form 4 filing was posted April 17, 2026. The sale follows robust share-price appreciation over the past year and comes amid the company repo…
Cybin (CYBN) is a clinical-stage neuropsychiatric company trading at a modest ~$298M market cap. Recent regulatory and policy signals, expanding analyst coverage, and a live Phase II program create an asymmetric risk/reward for a tactical long. We upgrade to a buy and lay out a clear entry at $8.00, a stop at $5.50 and targets at $12.00 (mid) and $…
HRT FINANCIAL LP, listed as a 10% owner of Onconetix, Inc. (NASDAQ:ONCO), reported a sequence of transactions in mid-April that resulted in $110,169 in share sales and a smaller purchase of $25,284. The trades left HRT with 83,359 Class A shares. The activity coincides with Onconetix stock trading near its 52-week low and a suite of corporate devel…
Badger Meter Inc. CEO Kenneth Bockhorst purchased 2,200 shares on April 21, 2026, investing $258,573 and raising his direct holding to 51,676 shares. The transaction occurred amid a sharp share-price decline and a first-quarter fiscal 2026 earnings and revenue miss that prompted analysts to lower price targets while retaining positive ratings.
President Donald Trump has nominated Christopher Phelan, a long-serving University of Minnesota economics professor and former senior economist at the Federal Reserve Bank of Minneapolis, to serve as his chief economic adviser. The nomination, announced by the White House, aims to fill the vacancy created when Stephen Miran left the Council of Econ…
Travere (TVTX) looks attractively positioned if FILSPARI (sparsentan) captures FSGS market share or becomes an acquisition target. The stock trades at a market cap of roughly $3.58B despite negative earnings, modest free cash flow, and material leverage. This trade idea lays out a clear entry, stop and target with a long-term horizon while flagging…
Advanced Micro Devices (AMD) has rallied into fresh 52-week highs with strong momentum and improving data-center positioning. I see a clear, actionable long setup into $300 over the next 45 trading days, with an entry at $285, a stop at $265 and a $300 target. The thesis leans on accelerating AI demand, improving free cash flow and conservative bal…
Amnesty International reported that disappearances in Mexico rose to 133,500 cases in 2025, while attacks on human rights defenders, journalists and searchers for the disappeared continued. The rights group said disappearances increased 10.5% by December even as murders fell 27.4%, and warned that threats and violence against advocates have grown a…
Randy Soule, a ten percent stakeholder in XCF Global, Inc. (SAFX), sold 1,261,830 shares of Class A common stock on March 12, 2026, for a total of $656,151 at $0.52 per share. The sale was disclosed in an SEC Form 4 filing and follows steep recent declines in the company’s share price. Separately, XCF Global filed its first Form 10-K and reported o…
